NEW YORK (GenomeWeb News) – BioFocus today said that it has signed an agreement to offer ChanTest's cell line library and Channel Panel profiling services.

Saffron Walden, UK-based BioFocus said that the alliance will expand its offerings in the fields of ion channel, GPCR, and transporter targets for drug discovery. ChanTest's cell line library contains more than 200 products, BioFocus noted.

Chris Mathes, chief commercial officer of Cleveland-based ChanTest, said that the collaboration "fits well with ChanTest's integrated CRO strategy."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.